Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

A human model of Buruli ulcer: Provisional protocol for a Mycobacterium ulcerans controlled human infection study.

Muhi S. et al, (2024), Wellcome Open Research, 9, 488 - 488

Ethical issues in Nipah virus control and research: addressing a neglected disease.

Johnson T. et al, (2024), J Med Ethics, 50, 612 - 617

A human model of Buruli ulcer: Provisional protocol for a Mycobacterium ulcerans controlled human infection study.

Muhi S. et al, (2024), Wellcome Open Research, 9, 488 - 488

Burdens of infection control on healthcare workers: a scoping review.

Ungar R. et al, (2024), J Hosp Infect, 146, 76 - 81

Herd immunity to endemic diseases: Historical concepts and implications for public health policy

Robertson D. et al, (2024), Journal of Evaluation in Clinical Practice

An Analysis of Controlled Human Infection Studies Registered on ClinicalTrials.gov

Toomey D. et al, (2024)

The Ethical Obligation for Research During Public Health Emergencies: Insights From the COVID-19 Pandemic.

Barosa M. et al, (2024), Med Health Care Philos, 27, 49 - 70

Ethical approval for controlled human infectious model clinical trial protocols - A workshop report.

Jamrozik E. et al, (2024), Biologicals, 85

A human model of Buruli ulcer: Provisional protocol for a <i>Mycobacterium ulcerans</i> controlled human infection study.

Muhi S. et al, (2024), Wellcome open research, 9

Controlled human infection trials: Legitimacy and conditions of implementation in France.

Morin A-L. et al, (2024), Therapie, 79, 35 - 45

Ethics, equity, climate change, and infectious disease research: a scoping review

Markle H. et al, (2023), Wellcome Open Research, 8, 581 - 581

[Not Available].

Morin A-L. et al, (2023), Therapie

Expertise, disagreement, and trust in vaccine science and policy. The importance of transparency in a world of experts

Giubilini A. et al, (2023), Diametros: A Journal of Philosophy

A Scalar Approach to Vaccination Ethics

Jamrozik E. et al, (2023), Journal of Ethics

Public health use of HIV phylogenetic data in sub-Saharan Africa: ethical issues.

Jamrozik E. et al, (2023), BMJ Glob Health, 8

Ethics of antibiotic allergy.

Xiang YY. et al, (2023), J Med Ethics

Herd immunity, vaccination and moral obligation.

Bullen M. et al, (2023), J Med Ethics

Strategic and scientific contributions of human challenge trials for vaccine development: facts versus fantasy

Jamrozik E., (2023), Lancet Infectious Diseases

University-age vaccine mandates: reply to Lam and Nichols.

Høeg TB. et al, (2023), J Med Ethics

Quantifying the impact of individual and collective compliance with infection control measures for ethical public health policy.

Roberts D. et al, (2023), Sci Adv, 9

Load More

Include forthcoming?